Bristol-Myers Squibb and Pfizer announce charitable donations of more than $1 million to support cardiovascular education
- Details
- Category: Bristol-Myers Squibb

Merck to acquire Sigma-Aldrich to enhance position in attractive life science industry
- Details
- Category: Merck Group

AstraZeneca and Lilly announce alliance to develop and commercialise BACE inhibitor AZD3293 for Alzheimer's disease
- Details
- Category: AstraZeneca

Roche again ranked most sustainable healthcare company in the Dow Jones Sustainability Indices
- Details
- Category: Roche

GSK joins with research councils in UK and South Africa to tackle non-communicable diseases
- Details
- Category: GlaxoSmithKline

Safety and sustained benefits of Adempas® from Bayer confirmed by results of long-term studies
- Details
- Category: Bayer

AstraZeneca and Redx Pharma agree research collaboration
- Details
- Category: AstraZeneca

More Pharma News ...
- Novartis' new heart failure medicine LCZ696 cut cardiovascular deaths by 20% vs. ACE-inhibitor in landmark PARADIGM-HF trial
- New data indicates Brilinta/Brilique™ has the flexibility to be initiated pre-hospital or in hospital in STEMI patients
- Ebola vaccine trials fast-tracked by international consortium
- Pfizer and Merck to collaborate on study evaluating novel anti-cancer combination regimen
- Roche and InterMune reach definitive merger agreement
- Novartis provides drug candidate compounds to TB Alliance
- United States Department of Justice closes investigation into PLATO clinical trial for Brilinta